Found 79 matching trials
Parsaclisib Plus the Standard Drug Therapy in Patients With Newly Diagnosed, High Risk Diffuse Large B-cell Lymphoma PHASE1 This phase I/Ib trial studies the side effects and best dose of parsaclisib...
Show More Status
Active Not Recruiting
Location
Mayo Clinic in Arizona
Learn More & Join Trial
Efficacy and Safety of 4.5mg PEG-rhG-CSF Per Cycle in Preventing Neutropenia After Intensive Chemotherapy for Breast Cancer PHASE4 This is a prospective, single-center, single-arm clinical study, to evaluat...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial
Study Comparing TPI-120 and Neulasta Administered Through Subcutaneous Route in Healthy Adult Subjects PHASE1 This is a single or up to 2 centers, double-blind, randomized, single-dose,...
Show More Learn More & Join Trial
To Evaluate the Efficacy and Safety of PEG-rhG-CSF(Jinyouli®) in Reducing Neutropenia in Patients With Cervical Cancer PHASE4 A Prospective, open, randomized, controlled clinical study to evaluate the ...
Show More Location
Department of Radiation Oncology, Xijing Hospital, Fourth Military Medical University
Learn More & Join Trial
A Clinical Study of Autologous Peripheral Blood Stem Cell Mobilization for PEG-G-CSF PHASE4 Have a comparison between pegylated recombinant human granulocyte colony st...
Show More Location
Multiple Locations
Learn More & Join Trial
Evaluate the Efficacy and Safety of the Prophylactic Use of PEG-rhG-CSF in Children With Hematological Malignancies NA The incidence of infectious complications in hematological malignancies is ...
Show More Location
Children's Hospital of Fudan University
Learn More & Join Trial
Dose Individualization of Antineoplastic Drugs and Anti-Infective Drug in Children With Hematoplastic Disease PHASE4 The investigators' purpose was to assess the feasibility of dosage individu...
Show More Location
Department of Pediatrics, the Affiliated Hospital of Xuzhou Medical University
Learn More & Join Trial
Comparison Study of EAP and Disease-Specific Chemotherapy Regimens in Hematopoietic Stem Cell Mobilization for Lymphoma PHASE3 This study utilizes a prospective, multicenter, randomized two-arm design t...
Show More Location
Dongyang People's Hospital
Learn More & Join Trial
A Study Comparing Pegylated Filgrastim and Filgrastim in Support for Chemotherapy PHASE3 Neutropenia is one of the most frequent adverse effects of chemotherapy, an...
Show More Location
Multiple Locations
Learn More & Join Trial
Salvage Chemoradiation Therapy for Recurrence After Radical Surgery or Palliative Surgery in Esophageal Cancer Patients PHASE3 Currently, adjuvant therapy is not recommended for patients with esophageal...
Show More Location
Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC)
Learn More & Join Trial